Genetically engineered pig models for human diseases

Annual Review of Animal Biosciences

Volumn 1, Issue , 2013, Pages 203-219

  Prather, Randall S ^a   Lorson, Monique ^b   Ross, Jason W ^c   Whyte, Jeffrey J ^a   Walters, Eric ^a  

^a National Swine Resource and Research Center   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

^c IOWA STATE UNIVERSITY   (United States)

Author keywords

cloning; genetic engineering; swine

Indexed keywords

ANIMAL; DISEASE MODEL; GENETIC ENGINEERING; GENETICS; HUMAN; PIG; TRANSGENIC ANIMAL; VETERINARY;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; DISEASE MODELS, ANIMAL; GENETIC ENGINEERING; HUMANS; SWINE;

EID: 84898838397     PISSN: 21658102     EISSN: 21658110     Source Type: Journal    
DOI: 10.1146/annurev-animal-031412-103715     Document Type: Article

References (99)

1. Box GEP, Draper NR. 1987. Empirical Model Building. New York: John Wiley & Sons
2. Turk JR, Laughlin MH. 2004. Physical activity and atherosclerosis: Which animal model? Can. J. Appl. Physiol. 29(5):657-83
3. Ishii A, Viñuela F, Murayama Y, Yuki I, Nien YL, et al. 2006. Swine model of carotid artery atherosclerosis: experimental induction by surgical partial ligation and dietary hypercholesterolemia. Am. J. Neuroradiol. 27(9):1893-99
4. Herkenne C, Naik A, Kalia YN, Hadgraft J, Guy RH. 2006. Pig ear skin ex vivo as a model for in vivo dermatopharmacokinetic studies in man. Pharm. Res. 23(8):1850-56
5. Graham JS, Reid FM, Smith JR, Stotts RR, Tucker FS, et al. 2000. A cutaneous full-thickness liquid sulfur mustard burn model in weanling swine: clinical pathology and urinary excretion of thiodiglycol. J. Appl. Toxicol. 20:S161-72
6. Du ZQ, Vincent-Naulleau S, Gilbert H, Vignoles F, Créchet F, et al. 2007. Detection of novel quantitative trait loci for cutaneous melanoma by genome-wide scan in the MeLiM swine model. Int. J. Cancer 120(2): 303-20
7. Dyson MC, Alloosh M, Vuchetich JP, Mokelke EA, Sturek M. 2006. Components of metabolic syndrome and coronary artery disease in female Ossabaw swine fed excess atherogenic diet. Comp. Med. 56(1):35-45
8. Noel JM, Fernandez de Castro JP, Demarco PJ Jr, Franco LM,WangW, et al. 2012. Iodacetic acid, but not sodium iodate, creates an inducible swine model of photoreceptor damage. Exp. Eye Res. 97(1): 137-47
9. Peters LL, Robledo RF, Bult CJ, Churchill GA, Paigen BJ, Svenson KL. 2007. The mouse as a model for human biology: a resource guide for complex trait analysis. Nat. Rev. Genet. 8(1):58-69
10. Trancikova A, Ramonet D, Moore DJ. 2011. Genetic mouse models of neurodegenerative diseases. Prog. Mol. Biol. Transl. Sci. 100:419-82
11. Walters EM, Wolf E, Whyte JJ, Mao J, Renner S, et al. 2012. Completion of the swine genome will simplify the production of swine as a large animal biomedical model. BMC Med. Genom. 5:55.
12. Whyte JJ, Prather RS. 2011. Genetic modifications of pigs for medicine and agriculture. Mol. Reprod. Dev. 78(10-11):879-91
13. Hammer RE, Pursel VG, Rexroad CE Jr, Wall RJ, Bolt DJ, et al. 1985. Production of transgenic rabbits, sheep and pigs by microinjection. Nature 315(6021):680-83
14. Lavitrano M, Forni M, Varzi V, Pucci L, Bacci ML, et al. 1997. Sperm-mediated gene transfer: production of pigs transgenic for a human regulator of complement activation. Transplant. Proc. 29(8): 3508-9
15. Cabot RA, Kühholzer B, Chan AW, Lai L, Park KW, et al. 2001. Transgenic pigs produced using in vitro matured oocytes infected with a retroviral vector. Anim. Biotechnol. 12(2):205-14
16. Lai L, Sun Q, Wu G, Murphy CN, Kühholzer B, et al. 2001. Development of porcine embryos and offspring after intracytoplasmic sperm injection with liposome transfected or non-transfected sperm into in vitro matured oocytes. Zygote 9(4):339-46
17. Pereyra-Bonnet F, Fernández-Martín R, Olivera R, Jarazo J, Vichera G, et al. 2008. A unique method to produce transgenic embryos in ovine, porcine, feline, bovine and equine species. Reprod. Fertil. Dev. 20(7):741-49
18. Park KW, Cheong HT, Lai L, Im GS, Kühholzer B, et al. 2001. Production of nuclear transfer-derived swine that express the enhanced green fluorescent protein. Anim. Biotechnol. 12(2):173-81
19. Lai L, Kolber-Simonds D, Park KW, Cheong HT, Greenstein JL, et al. 2002. Production of a-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science 295(5557):1089-92
20. Whyte JJ, Zhao J, Wells KD, Samuel MS, Whitworth KM, et al. 2011. Gene targeting with zinc finger nucleases to produce cloned eGFP knockout pigs. Mol. Reprod. Dev. 78(1):2
21. Whyte JJ, Prather RS. 2012. Cell Biology Symposium: Zinc finger nucleases to create custom-designed modifications in the swine (Sus scrofa) genome. J. Anim. Sci. 90(4):1111-17
22. Garrels W, Holler S, Struckmann C, Taylor U, Ehling C, et al. 2011. Analysis of fluorophoreexpressing spermatozoa from transgenic boars produced by sleeping beauty transposition. Reprod. Fertil. Dev. 23:260
23. Kim SJ, Koo OJ, Park SJ, Moon JH, Kwon DK, et al. 2011. Inducible fluorescent protein (RFP) expression in porcine fibroblasts and transgenic cloned embryos using piggyback transposition. Reprod. Fertil. Dev. 23:262
24. Miller JC, Tan S, Qiao G, Barlow KA, Wang J, et al. 2011. A TALE nuclease architecture for efficient genome editing. Nat. Biotechnol. 29(2):143-48
25. Rogers CS, Hao Y, Rokhlina T, Samuel M, Stoltz DA, et al. 2008. Production of CFTR-null and CFTRDF508 heterozygous pigs by adeno-associated virus-mediated gene targeting and somatic cell nuclear transfer. J. Clin. Investig. 118(4):1571-77
26. Hofmann A, Kessler B, Ewerling S, Weppert M, Vogg B, et al. 2003. Efficient transgenesis in farm animals by lentiviral vectors. EMBO Rep. 4(11):1054-60
27. Kolber-Simonds D, Lai L, Watt SR, Denaro M, Arn S, et al. 2004. Production of a-1,3-galactosyltransferase null pigs by means of nuclear transfer with fibroblasts bearing loss of heterozygosity mutations. Proc. Natl. Acad. Sci. USA 101(19):7335-40
28. Phelps CJ, Koike C, Vaught TD, Boone J, Wells KD, et al. 2003. Production of a1,3-galactosyltransferasedeficient pigs. Science 299(5605):411-14
29. Welsh MJ, Rogers CS, Stoltz DA, Meyerholz DK, Prather RS. 2009. Development of a porcine model of cystic fibrosis. Trans. Am. Clin. Climatol. Assoc. 120:149-62
30. Meyerholz DK, Stoltz DA, Pezzulo AA, Welsh MJ. 2010. Pathology of gastrointestinal organs in a porcine model of cystic fibrosis. Am. J. Pathol. 176(3):1377-89
31. Rogers CS, Stoltz DA, Meyerholz DK, Ostedgaard LS, Rokhlina T, et al. 2008. Disruption of the CFTR gene produces a model of cystic fibrosis in newborn pigs. Science 321(5897):1837-41
32. Meyerholz DK, Stoltz DA, Namati E, Ramachandran S, Pezzulo AA, et al. 2010. Loss of cystic fibrosis transmembrane conductance regulator function produces abnormalities in tracheal development in neonatal pigs and young children. Am. J. Respir. Crit. Care Med. 182(10):1251-61
33. Stoltz DA,Meyerholz DK, Pezzulo AA, Ramachandran S, Rogan MP, et al. 2010. Cystic fibrosis pigs develop lung disease and exhibit defective bacterial eradication at birth. Sci. Transl. Med. 2(29): 29ra31
34. Rogan MP, Reznikov LR, Pezzulo AA, Gansemer ND, Samuel M, et al. 2010. Pigs and humans with cystic fibrosis have reduced insulin-like growth factor 1 (IGF1) levels at birth. Proc. Natl. Acad. Sci. USA 107(47):20571-75
35. Scheuner D, Eckman C, Jensen M, Song X, Citron M, et al. 1996. Secreted amyloid b-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat. Med. 2(8):864-70
36. McGurk L, Bonini NM. 2011. Yeast informs Alzheimer's disease. Science 334(6060):1212-13
37. Neve RL, Finch EA, Dawes LR. 1988. Expression of the Alzheimer amyloid precursor gene transcripts in the human brain. Neuron 1(8):669-77
38. Kragh PM, Nielsen AL, Li J, Du Y, Lin L, et al. 2009. Hemizygous minipigs produced by random gene insertion and handmade cloning express the Alzheimer's disease-causing dominant mutation APPsw. Transgenic Res. 18(4):545-58
39. Senée V, Chelala C, Duchatelet S, Feng D, Blanc H, et al. 2006. Mutations in GLIS3 are responsible for a rare syndrome with neonatal diabetes mellitus and congenital hypothyroidism. Nat. Genet. 38(6): 682-87
40. Whyte JJ, Isom SC, Samuel M, Asadi A, Kieffer TJ, Prather RS. 2011. Human Insulin Expression in Intestinal K-Cells of Transgenic Swine. Presented at Swine Biomed. Res. Conf. July 17-19, Chicago, IL.
41. Renner S, Fehlings C, Herbach N, Hofmann A, von Waldthausen DC, et al. 2010. Glucose intolerance and reduced proliferation of pancreatic b-cells in transgenic pigs with impaired glucose-dependent insulinotropic polypeptide function. Diabetes 59(5):1228-38
42. Yamagata K. 2003. Regulation of pancreatic b-cell function by the HNF transcription network: lessons from maturity-onset diabetes of the young (MODY). Endocr. J. 50(5):491-99
43. Yamagata K, Oda N, Kaisaki PJ, Menzel S, Furuta H, et al. 1996. Mutations in the hepatocyte nuclear factor-1a gene in maturity-onset diabetes of the young (MODY3). Nature 384(6608):455-58
44. Umeyama K, Watanabe M, Saito H, Kurome M, Tohi S, et al. 2009. Dominant-negative mutant hepatocyte nuclear factor 1a induces diabetes in transgenic-cloned pigs. Transgenic Res. 18(5):697-706
45. Swindle MM. 2007. Swine in the Laboratory: Surgery, Anesthesia, Imaging, and Experimental Techniques. Boca Raton, FL: CRC
46. Vilahur G, Padro T, Badimon L. 2011. Atherosclerosis and thrombosis: insights from large animal models. J. Biomed. Biotechnol. 2011:907575
47. Young LH. 2010. Diet-induced obesity obstructs insulin signaling in the heart. Am. J. Physiol. Heart Circ. Physiol. 298(2):H306-7
48. Jensen TW, Mazur MJ, Pettigew JE, Perez-Mendoza VG, Zachary J, Schook LB. 2010. A cloned pig model for examining atherosclerosis induced by high fat, high cholesterol diets. Anim. Biotechnol. 21(3):179-87
49. Saeki K, Matsumoto K, Kinoshita M, Suzuki I, Tasaka Y, et al. 2004. Functional expression of a D12 fatty acid desaturase gene from spinach in transgenic pigs. Proc. Natl. Acad. Sci. USA 101(17):6361-66
50. Lai L, Kang JX, Li R, Wang J, Witt WT, et al. 2006. Generation of cloned transgenic pigs rich in omega-3 fatty acids. Nat. Biotechnol. 24(4):435-36
51. Fulton D, Gratton JP, McCabe TJ, Fontana J, Fujio Y, et al. 1999. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399(6736):597-601
52. Hao YH, Yong HY, Murphy CN, Wax D, Samuel M, et al. 2006. Production of endothelial nitric oxide synthase (eNOS) over-expressing piglets. Transgenic Res. 15(6):739-50
53. Whyte JJ, Laughlin MH. 2010. Placentation in the pig visualized by eGFP fluorescence in eNOS overexpressing cloned transgenic swine. Mol. Reprod. Dev. 77(7):565
54. Drouin A, Thorin E. 2009. Flow-induced dilation is mediated by Akt-dependent activation of endothelial nitric oxide synthase-derived hydrogen peroxide in mouse cerebral arteries. Stroke 40(5):1827-33
55. Collins AR, Lyon CJ, Xia X, Liu JZ, Tangirala RK, et al. 2009. Age-accelerated atherosclerosis correlates with failure to upregulate antioxidant genes. Circ. Res. 104(6):e42-54
56. Whyte JJ, Samuel M, Mahan E, Padilla J, Simmons GH, et al. 2011. Vascular endothelium-specific overexpression of human catalase in cloned pigs. Transgenic Res. 20(5):989-1001
57. Yang D, Yang H, Li W, Zhao B, Ouyang Z, et al. 2011. Generation of PPARg mono-allelic knockout pigs via zinc-finger nucleases and nuclear transfer cloning. Cell Res. 21(6):979-82
58. Nicholls SJ, Uno K. 2012. Peroxisome proliferator-activated receptor (PPAR a/g) agonists as a potential target to reduce cardiovascular risk in diabetes. Diabetes Vasc. Dis. Res. 9(2):89-94
59. Olsson JE, Gordon JW, Pawlyk BS, Roof D, Hayes A, et al. 1992. Transgenic mice with a rhodopsin mutation (Pro23His): a mouse model of autosomal dominant retinitis pigmentosa. Neuron 9(5): 815-30
60. Mao H, James T Jr, Schwein A, Shabashvili AE, Hauswirth WW, et al. 2011. AAV delivery of wild-type rhodopsin preserves retinal function in a mouse model of autosomal dominant retinitis pigmentosa. Hum. Gene Ther. 22(5):567-75
61. Ji Y, Zhu CL, Grzywacz NM,Lee EJ. 2012. Rearrangement of the cone mosaic in the retina of the rat model of retinitis pigmentosa. J. Comp. Neurol. 520(4):874-88
62. Kijas JW, Cideciyan AV, Aleman TS, Pianta MJ, Pearce-Kelling SE, et al. 2002. Naturally occurring rhodopsin mutation in the dog causes retinal dysfunction and degeneration mimicking human dominant retinitis pigmentosa. Proc. Natl. Acad. Sci. USA 99(9):6328-33
63. Ross JW, Fernandez de Castro JP, Zhao J, Samuel M, Walters E, et al. 2012. Generation of an inbred miniature pig model of retinitis pigmentosa. Investig. Ophthalmol. Vis. Sci. 53(1):501-7
64. Petters RM, Alexander CA, Wells KD, Collins EB, Sommer JR, et al. 1997. Genetically engineered large animal model for studying cone photoreceptor survival and degeneration in retinitis pigmentosa. Nat. Biotechnol. 15(10):965-70
65. Szél A, Röhlich P, Caffé AR, Juliusson B, Aguirre G, Van Veen T. 1992. Unique topographic separation of two spectral classes of cones in the mouse retina. J. Comp. Neurol. 325(3):327-42
66. Roof DJ, Adamian M, Hayes A. 1994. Rhodopsin accumulation at abnormal sites in retinas of mice with a human P23H rhodopsin transgene. Investig. Ophthalmol. Vis. Sci. 35(12):4049-62
67. Beauchemin ML, Babel J. 1973. Proceedings: A preliminary study on the ultrastructure of the pig retina. Exp. Eye Res. 17(4):400
68. Braekevelt CR. 1983. Fine structure of the retinal rods and cones in the domestic pig. Graefes Arch. Clin. Exp. Ophthalmol. 220(6):273-78
69. Wang W, Fernandez de Castro J, Vukmanic E, Zhou L, Emery D, et al. 2011. Selective rod degeneration and partial cone inactivation characterize an iodoacetic acid model of Swine retinal degeneration. Investig. Ophthalmol. Vis. Sci. 52(11):7917-23
70. Tucker BA, Park IH, Qi SD, Klassen HJ, Jiang C, et al. 2011. Transplantation of adult mouse iPS cellderived photoreceptor precursors restores retinal structure and function in degenerative mice. PLoS ONE 6(4):e18992
71. Millington-Ward S, Chadderton N, O'Reilly M, Palfi A, Goldmann T, et al. 2011. Suppression and replacement gene therapy for autosomal dominant disease in a murine model of dominant retinitis pigmentosa. Mol. Ther. 19(4):642-49
72. Wee CD, Kong L, Sumner CJ. 2010. The genetics of spinal muscular atrophies. Curr. Opin. Neurol. 23(5): 450-58
73. Prior TW. 2010. Perspectives and diagnostic considerations in spinal muscular atrophy. Genet. Med. 12(3):145-52
74. Wirth B. 2000. An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA). Hum. Mutat. 15(3):228-37
75. Lefebvre S, Bürglen L, Reboullet S, Clermont O, Burlet P, et al. 1995. Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80(1):155-65
76. Lorson CL, Hahnen E, Androphy EJ, Wirth B. 1999.Asingle nucleotide in theSMNgene regulates splicing and is responsible for spinal muscular atrophy. Proc. Natl. Acad. Sci. USA 96(11):6307-11
77. Kolb SJ, Battle DJ, Dreyfuss G. 2007. Molecular functions of the SMN complex. J. Child Neurol. 22(8): 990-94
78. Paushkin S, Gubitz AK, Massenet S, Dreyfuss G. 2002. The SMN complex, an assemblyosome of ribonucleoproteins. Curr. Opin. Cell Biol. 14(3):305-12
79. Burghes AH, Beattie CE. 2009. Spinal muscular atrophy: Why do low levels of survival motor neuron protein make motor neurons sick? Nat. Rev. Neurosci. 10(8):597-609
80. Bowerman M, Murray LM, Beauvais A, Pinheiro B, Kothary R. 2012. A critical smn threshold in mice dictates onset of an intermediate spinal muscular atrophy phenotype associated with a distinct neuromuscular junction pathology. Neuromuscul. Disord. 22(3):263-76
81. Kong L, Wang X, Choe DW, Polley M, Burnett BG, et al. 2009. Impaired synaptic vesicle release and immaturity of neuromuscular junctions in spinal muscular atrophy mice. J. Neurosci. 29(3):842-51
82. Park GH, Kariya S, Monani UR. 2010. Spinal muscular atrophy: new and emerging insights from model mice. Curr. Neurol. Neurosci. Rep. 10(2):108-17
83. Lorson MA,Spate LD, Samuel MS,Murphy CN, Lorson CL, et al. 2011. Disruption of the Survival Motor Neuron (SMN) gene in pigs using ssDNA. Transgenic Res. 20(6):1293-304
84. Gusella JF, Wexler NS, Conneally PM, Naylor SL, Anderson MA, et al. 1983. A polymorphic DNA marker genetically linked to Huntington's disease. Nature 306(5940):234-38
85. Reiner A, Dragatsis I, Dietrich P. 2011. Genetics and neuropathology of Huntington's disease. Int. Rev. Neurobiol. 98:325-72
86. Yuan J, Yankner BA. 2000. Apoptosis in the nervous system. Nature 407(6805):802-9
87. Mattson MP. 2000. Apoptosis in neurodegenerative disorders. Nat. Rev. Mol. Cell Biol. 1(2):120-29
88. Friedlander RM. 2003. Apoptosis and caspases in neurodegenerative diseases. N. Engl. J. Med. 348(14): 1365-75
89. Walker FO. 2007. Huntington's disease. Lancet 369(9557):218-28
90. Yang SH, Chan AW. 2011. Transgenic animal models of Huntington's disease. Curr. Top. Behav. Neurosci. 7:61-85
91. Uchida M, Shimatsu Y, Onoe K, Matsuyama N, Niki R, et al. 2001. Production of transgenic miniature pigs by pronuclear microinjection. Transgenic Res. 10(6):577-82
92. Yang D, Wang CE, Zhao B, Li W, Ouyang Z, et al. 2010. Expression of Huntington's disease protein results in apoptotic neurons in the brains of cloned transgenic pigs. Hum. Mol. Genet. 19(20):3983-94
93. Am. Cancer Soc. 2012. Cancer Facts and Figures 2012. Atlanta, GA: Am. Cancer Soc. http://www.cancer. org/acs/groups/content/@epidemiologysurveilance/ documents/document/acspc-031941.pdf
94. Yamakawa H, Nagai T, Harasawa R, Yamagami T, Takahashi J, et al. 1999. Production of transgenic pig carrying MMTV/v-Ha-ras. J. Reprod. Dev. 45:111-18
95. Adam SJ, Counter CM. 2008.Amethod to generate genetically defined tumors in pigs. Methods Enzymol. 439:39-51
96. Rivenbark AG, Stolzenburg S, Beltran AS, Yuan X, Rots M, et al. 2012. Epigenetic reprogramming of cancer cells via targeted DNA methylation. Epigenetics 7(4):350-60
97. Klymiuk N, Thirion C, Burkhardt K, Wuensch A, Krause S, et al. 2012. Tailored pig model of Duchenne muscular dystrophy. Reprod. Fertil. Dev. 24:231
98. McCalla-Martin AC, Chen X, Linder KE, Estrada JL, Piedrahita JA. 2009. Varying phenotypes in swine versus murine transgenic models constitutively expressing the samehuman Sonic hedgehog transcriptional activator, K5-HGL12DN. Transgenic Res. 19:869-87
99. Klymiuk N, Böcker W, Schönitzer V, Bähr A, Radic T, et al. 2012. First inducible transgene expression in porcine large animal models. FASEB J. 26(3):1086-99